OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Most gene fusions in cancer are stochastic events
Bertil Johansson, Fredrik Mertens, Tommy Schyman, et al.
Genes Chromosomes and Cancer (2019) Vol. 58, Iss. 9, pp. 607-611
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
Marta Sbaraglia, Elena Bellan, Angelo Paolo Dei Tos
Pathologica (2020) Vol. 113, Iss. 2, pp. 70-84
Open Access | Times Cited: 717

Emerging entities in NUTM1‐rearranged neoplasms
Christopher R. McEvoy, Stephen B. Fox, Owen W.J. Prall
Genes Chromosomes and Cancer (2020) Vol. 59, Iss. 6, pp. 375-385
Open Access | Times Cited: 67

Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS
Ianthe A. E. M. van Belzen, Casey Cai, Marc van Tuil, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18

Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS
Anna Stengel, Rabia Shahswar, Torsten Haferlach, et al.
Blood Advances (2020) Vol. 4, Iss. 21, pp. 5393-5401
Open Access | Times Cited: 39

Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion Transcripts
Neetha Nanoth Vellichirammal, Abrar Albahrani, Jasjit K. Banwait, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 19, pp. 1379-1398
Open Access | Times Cited: 38

Genetic and environmental associations of nonspecific chromosomal aberrations
Kari Hemminki, Yasmeen Niazi, Ľudmila Vodičková, et al.
Mutagenesis (2024)
Open Access | Times Cited: 4

Sarcoma care in the era of precision medicine
Karin Wallander, Ingegerd Öfverholm, Kjetil Boye, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 6, pp. 690-707
Open Access | Times Cited: 11

Decoding Oncofusions: Unveiling Mechanisms, Clinical Impact, and Prospects for Personalized Cancer Therapies
Kari Salokas, Giovanna Dashi, Markku Varjosalo
Cancers (2023) Vol. 15, Iss. 14, pp. 3678-3678
Open Access | Times Cited: 9

Pathogenetic and molecular classifications of soft tissue and bone tumors: A 2024 update
Andrei Patrichi, Simona Gurzu
Pathology - Research and Practice (2024) Vol. 260, pp. 155406-155406
Open Access | Times Cited: 3

Fusion transcripts: Unexploited vulnerabilities in cancer?
Carla Neckles, Soumya Sundara Rajan, Natasha J. Caplen
Wiley Interdisciplinary Reviews - RNA (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 24

Deep sequencing of myxoinflammatory fibroblastic sarcoma
Elsa Arbajian, Jakob Hofvander, Linda Magnusson, et al.
Genes Chromosomes and Cancer (2020) Vol. 59, Iss. 5, pp. 309-317
Closed Access | Times Cited: 23

Fusions involving BCOR and CREBBP are rare events in infiltrating glioma
David J. Pisapia, Kentaro Ohara, Rohan Bareja, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 21

PVT1: A long non-coding RNA recurrently involved in neoplasia-associated fusion transcripts
Doron Tolomeo, Antonio Agostini, Grazia Visci, et al.
Gene (2021) Vol. 779, pp. 145497-145497
Closed Access | Times Cited: 20

circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype‐definition in small cell lung cancer
Doron Tolomeo, Debora Traversa, Santina Venuto, et al.
Genes Chromosomes and Cancer (2022) Vol. 62, Iss. 7, pp. 377-391
Open Access | Times Cited: 13

A cloud‐based resource for genome coordinate‐based exploration and large‐scale analysis of chromosome aberrations and gene fusions in cancer
Janet Wang, Jeanne Zheng, Eun Kyong Lee, et al.
Genes Chromosomes and Cancer (2023) Vol. 62, Iss. 8, pp. 441-448
Open Access | Times Cited: 8

Interstitial Deletions Generating Fusion Genes
Ioannis Panagopoulos, Sverre Heim
Cancer Genomics & Proteomics (2021) Vol. 18, Iss. 3, pp. 167-196
Open Access | Times Cited: 15

ESR1 fusions invoke breast cancer subtype-dependent enrichment of ligand independent oncogenic signatures and phenotypes
Megan E. Yates, Hunter Waltermire, Kanako Mori, et al.
Endocrinology (2024) Vol. 165, Iss. 10
Open Access | Times Cited: 2

Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology
Shaham Beg, Rohan Bareja, Kentaro Ohara, et al.
Translational Oncology (2020) Vol. 14, Iss. 1, pp. 100944-100944
Open Access | Times Cited: 15

Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 years
Filip Tichánek, Asta Försti, Otto Hemminki, et al.
Cancer Epidemiology (2023) Vol. 92, pp. 102449-102449
Open Access | Times Cited: 5

Fast and sensitive validation of fusion transcripts in whole-genome sequencing data
Völundur Hafstað, Jari Häkkinen, Helena Persson
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5

Evolution in the management of soft tissue sarcoma: classification, surgery and use of radiotherapy
Angelo Paolo Dei Tos, Sylvie Bonvalot, Rick L. Haas
Expert Review of Anticancer Therapy (2020) Vol. 20, Iss. sup1, pp. 3-13
Closed Access | Times Cited: 10

Expanding the spectrum of mesenchymal neoplasms with NR1D1‐rearrangement
Maribel D. Lacambra, Cristina R. Antonescu, Chit Chow, et al.
Genes Chromosomes and Cancer (2022) Vol. 61, Iss. 7, pp. 420-426
Open Access | Times Cited: 6

Neoplasia-associated Chromosome Translocations Resulting in Gene Truncation
Ioannis Panagopoulos, Sverre Heim
Cancer Genomics & Proteomics (2022) Vol. 19, Iss. 6, pp. 647-672
Open Access | Times Cited: 6

Fusion sequencing via terminator‐assisted synthesis (FTAS‐seq) identifies TMPRSS2 fusion partners in prostate cancer
Ugnė Drazdauskienė, Žana Kapustina, Justina Medžiūnė, et al.
Molecular Oncology (2023) Vol. 17, Iss. 6, pp. 993-1006
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top